It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.
Part 1. Overview Information
Part 2. Full Text of the Announcement
Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission
Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information
The National Institutes of Health (NIH) Medical Scientist Partnership Program's (MSPP) overarching goal is to support highly promising predoctoral students during their mentored dissertation research and clinical training who are matriculated in (a) a formal combined M.D./Ph.D. program or other combined-doctoral degree training program (e.g., D.O./Ph.D., D.N.P./Ph.D., D.D.S./Ph.D., Au.D./Ph.D., D.V.M./Ph.D.), or (b) a clinical doctoral degree program plus a separate accredited Ph.D. program at their clinical degree school or other university.
MSPP Scholars will conduct their clinical degree education at their home institution and will conduct the Ph.D. portion of their education/experience in research laboratories in the NIH Intramural Research Program (IRP) through participation in the NIH Graduate Partnership Program (GPP). The students will receive their research degree from the home institution or one of the partnership institutions affiliated with the NIH. The IRP is the internal research program of the NIH, known for its synergistic approach to biomedical science. Its unique environment means the IRP can facilitate opportunities to conduct both long-term and high-impact research that would otherwise be difficult to undertake. With approximately 1,200 Principal Investigators and more than 4,000 Postdoctoral Fellows conducting basic, translational, and clinical research, the IRP is one of the largest biomedical research institutions in the world. Its unique funding environment means the IRP can facilitate opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake.
Potential areas of research within the IRP include, but are not limited to: biological chemistry, biophysics, bioinformatics, cellular and molecular biology, computational biosciences, epidemiology, developmental biology, genetics, immunology, neuroscience, oncology, biomedicine, pharmacology, physiology, bioethics, and technology development. MSPP Scholars will conduct their work with sponsors who have relevant experience in these areas of research in any of the participating NIH Institutes or Centers with an IRP.
The objective of the MSPP is to develop a diverse pool of well-trained clinician scientists, who will have the following technical, operational, and professional skills:
Nature of the research opportunity
The MSPP award will provide up to four years of support during the extramural clinical degree training depending on how many years of clinical research education the applicant has completed prior to the award, as described below. NIH intramural funding will support the Scholar while they are engaged in their doctoral research at NIH. Scholars may combine clinical degree training with the MSPP via two academic tracks:
For both Track 1 and Track 2 Scholars, the applicant does not need to identify the research project, clinical degree school, or dissertation mentor in their FM1 grant application. Some of this information will be required as just-in-time information prior to issuance of a Notice of Award. The NIH Institute or Center (IC) that will make the grant award will be based on the dissertation mentor's IC.
Additional clarifying information can be found at the this resource page.
See Section VIII. Other Information for award authorities and regulations.
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this FOA.
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Governments
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Applicant Organizations
Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.
Program Directors/Principal Investigators (PD(s)/PI(s))
All PD(s)/PI(s) must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons.If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.
All PD(s)/PI(s) must be registered with ORCiD. The personal profile associated with the PD(s)/PI(s) eRA Commons account must be linked to a valid ORCID ID. For more information on linking an ORCID ID to an eRA Commons personal profile see the ORCID topic in our eRA Commons online help.
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support. See, Reminder: Notice of NIH's Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities, NOT-OD-22-019.
By the time of award, the individual must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status).
By the time of award, the applicant must have a baccalaureate degree or equivalent, show evidence of high academic performance in the sciences, and commitment to a career as an independent physician-scientist or other clinician-scientist. They must be matriculated into a combined degree program (e.g., M.D./Ph.D., D.O./Ph.D., D.D.S./Ph.D., or D.V.M./Ph.D.) or clinical doctoral program with the option to pursue a Ph.D. during their clinical degree training and must be accepted into a laboratory within the NIH IRP to conduct their research training. Clinical degree programs that are eligible for the MSPP include, but are not limited to, the M.D., D.O., D.D.S., D.M.D., O.D., D.N.P., D.C., or Pharm.D. Applicants pursuing clinical degrees not listed above are encouraged to reach out to the scientific contacts listed in the FOA to determine eligibility.
This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
The NIH will not accept duplicate or highly overlapping applications under review at the same time per 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:
Individuals may receive up to 4 years of extramural support for their clinical degree from the MSPP. Furthermore, individuals are expected to be supported by the IRP for the completion of their Ph.D. dissertation research at the NIH for no more than 5 years, except under extenuating circumstances.
At the time of award, individuals are required to pursue their research training on a full-time basis, normally defined as 40 hours per week or as specified by the sponsoring institution in accordance with its own policies.
The application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this FOA. See your administrative office for instructions if you plan to use an institutional system-to-system solution.
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide,except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
All page limitations described in the SF424 (R&R) Application Guide and the Table of Page Limits must be followed.
Instructions for Application Submission
The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this FOA.
How to Apply
For Track 1 applicants, the applicant organization will be the National Institute of Allergy and Infectious Diseases (NIAID), and the applicants should work directly with NIAID staff to submit the applications. Applications will initially be assigned to NIAID, but that assignment will be transferred to the appropriate IC after receipt of the just-in-time information. Track 1 applicants should contact NIAID staff at least 90 days before the submission deadline by sending an email to NIHMSPPQuestions@niaid.nih.gov to receive specific instructions on how to apply.
Track 2 applicants will use their clinical degree school as the applicant organization and should contact that school's business or grants administration office (e.g., office of research administration, office of research administration services, office of financial and grants administration, office of sponsored programs) to receive specific instructions on how to apply. Track 2 applicants should contact their school's business or grants administration staff at least 90 days before the submission deadline.
Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies) using ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected, and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time. If a changed/corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission.
Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.
This grant application process does not include any of the steps needed for an applicant to apply to the NIH Graduate Partnership Program (GPP) and an accredited graduate department that can confer the Ph.D degree. Acceptance into the GPP and selection of an IRP mentor is not a prerequisite for applying for a FM1 grant, but is required before an award can be made. Therefore, for funding consideration, interested applicants should submit a FM1 application and a GPP application. GPP applications may be submitted via the NIH GPP Application Portal. Please note the following:
For more information on how to apply to the GPP, visit https://mdphd.gpp.nih.gov/prospective-students. Questions related to the NIH MD/PhD Program application may be directed to the program administrators at mdphd@od.nih.gov.
By submitting an application to NIAID, the expectation is that the applicants agree to allow NIAID to provide a copy of the peer review summary statement to the IRP GPP to be used as part of their evaluation and selection process.
All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:
Complete the Estimated Project Funding section as follows:
Total
Federal Funds Requested: Enter applicable stipend amount,
the estimated tuition and fees, and the standard institutional allowance
Total Non-Federal Funds: Enter
$0.
Total Federal &
Non-Federal Funds: Enter applicable stipend amount, the
estimated tuition and fees, and the standard institutional allowance
Estimated Program Income: Enter $0.
Note: Only the total should be entered in the fields for "Total Federal Funds Requested" and "Total Federal & Non-Federal Funds." Enter the total amount requested for the entire period of support. This amount should include the applicable stipend amount, the estimated tuition and fees, and the standard institutional allowance. Applicants should refer to the NIH Research Training and Career Development website for current stipend and other budgetary levels. A detailed budget and budget forms are not required and will not be accepted. If the application is under consideration for funding, detailed budget information will be requested with the 'Just in Time' request.
All instructions in the SF424 (R&R) Application Guide must be followed.
DO NOT USE this form.
All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:
Are Human Subjects Involved? Check 'NO'.
Are Vertebrate Animals Used? Check 'NO'.
Project Summary/Abstract: Upload attachment that indicates "Not Applicable".
Project Narrative: Upload attachment that indicates "Not Applicable".
Bibliography & References Cited: DO NOT PROVIDE ATTACHMENT.
Facilities & Other Resources: DO NOT PROVIDE ATTACHMENT.
Equipment: DO NOT PROVIDE ATTACHMENT.
Other Attachments: Applicants must provide the following, each as a separate PDF attachment. If the application is missing any of the attachments it will be considered incomplete and will be withdrawn.
Applicant s Background and Goals for Fellowship Training
3 page limit
The applicant's academic record should be provided including their most recent transcripts from prior baccalaureate, master's education, or other course work, and a description of their academic accomplishments and accolades. Accomplishments can include any honors, awards, internships, prizes, or other activities related to their academic or research work. The filename "Applicants_Background.pdf" must be used.
Research Experience and Accomplishments
3 page limit
Describe the applicant's prior research experience(s). The description should include information about where, when, duration of the research experience, and identity of primary and secondary research mentor(s). It should provide information about the projects that the applicant participated in and their specific role. Outputs such as publications, patents, abstracts, and presentations at scientific conferences, and awards or recognition resulting from the research should be described. The filename "Research_Experience.pdf" must be used.
Personal Statement
2 page limit
The applicant should provide a personal statement describing their interest and commitment to a career as a clinician scientist. The applicant should describe their research aspirations and goals and should describe how their current career trajectory will allow them to achieve those goals. The applicant should discuss their specific interest in, and motivation for, pursuing a combined degree that involves conducting their research training in the NIH IRP as well as the intended general or specific area(s) of research interest with a statement about whether basic, clinical, or a combination of these types of research is intended. The applicant should address the unique nature of a combined degree program and the synergistic benefits of integrating research and clinical training. The applicant should also provide a self-assessment of their scientific and academic strengths and any area of growth necessary to advance the applicant's career in biomedical research. The filename "Personal_Statement.pdf" must be used.2 page limit.
All instructions in the SF424 (R&R) Application Guide must be followed.
IMPORTANT REMINDER: The personal profile associated with the eRA Commons username entered in the Credential field for the PD/PI (fellowship applicant) must include an ORCID ID. For more information on linking an ORCID ID to an eRA Commons personal profile see the ORCID topic in our eRA Commons online help.
Profile Project Director/Principal Investigator Field-
Biographical sketch: Use Non-Fellowship Biographical Sketch format page.
Profile Senior Key Person 1: DO NOT USE. Only the PD/PI may serve as senior/key personnel.
Research
and Related Senior/Key Person Profile (Expanded) - Additional
Senior/Key Person Profiles(s): DO NOT USE. Only the PD/PI may serve as
senior/key personnel.
Research and Related
Senior/Key Person Profile (Expanded) - Additional
Biographical Sketch(es): DO NOT USE. Only the PD/PI may submit a Biographical
Sketch.
All instructions in the SF424 (R&R) Application Guide must be followed.
A detailed budget, budget forms and budget justification are not required at the time of submission. If the application is under consideration for funding, detailed budget information will be requested with the 'Just in Time' request.
Appendix
Limited items are allowed in the Appendix. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide; any instructions provided here are in addition to the SF424 (R&R) Application Guide instructions.
Applicants must carefully follow the SF424 (R&R) Application Guide, including the time period for when reference letters will be accepted. Reference letters should describe their relationship with the applicant, their own experience as a research trainee mentor, their assessment of the applicant's academic qualifications, and their assessment of the applicant's commitment and to, and potential as, a future biomedical scientist that utilizes the combined degree. Reference letters should provide examples of personal and professional growth as a consequence of the applicant's research experience and accomplishments, in addition to any areas of growth necessary to advance the applicant's career in biomedical research. Reference letters should also describe any area of growth necessary to advance the applicant's career in biomedical research. Applications lacking the appropriate required reference letters will not be reviewed. This is a separate process from submitting an application electronically. Reference letters are submitted directly through the eRA Commons Submit Reference Letter link and not through Grants.gov.
See Part 1. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov.
Part I. Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.
Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time. If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission.
Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.
Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.
This initiative is not subject to intergovernmental review.
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement. The National Research Service Award (NRSA) policies apply to this program. A Kirschstein-NRSA fellowship may not be held concurrently with another federally sponsored fellowship or similar Federal award that provides a stipend or otherwise duplicates provisions of this award.
Pre-award costs are generally not allowable for Fellowships.
Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide. Paper applications will not be accepted.
Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.
For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply Application Guide. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII.
Important
reminders:
All PD(s)/PI(s) must include their eRA Commons ID in the
Credential field of the Senior/Key Person Profile form. Failure
to register in the Commons and to include a valid PD/PI Commons ID in the
credential field will prevent the successful submission of an electronic
application to NIH.
The applicant organization must ensure that the unique entity identifier
provided on the application is the same identifier used in the organization s
profile in the eRA Commons and for the System for Award Management. Additional
information may be found in the SF424 (R&R) Application Guide.
See more
tips for avoiding common errors.
Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review, NIH. Applications that are incomplete or non-compliant will not be reviewed.
Applicants are required to follow the instructions for post-submission materials, as described in the policy. Any instructions provided here are in addition to the instructions in the policy. .
Only the review criteria described below will be considered in the review process. Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system.
Note: Effective for due dates on or after January 25, 2023, the Data Sharing Plan and Genomic Data Sharing Plan (GDS) will not be evaluated at time of review, and a Data Management and Sharing Plan is not applicable for this FOA.
Reviewers will provide an overall impact score to reflect their assessment of the likelihood that the fellowship will enhance the applicant’s potential for, and commitment to, a productive independent scientific research career in a health-related field as a combined degree scientist, in consideration of the scored and additional review criteria.
Reviewers will consider each of the review criteria below in the determination of merit and give a separate score for each. An application does not need to be strong in all categories to be judged likely to transition to a biomedical career in that utilizes the combined degree.
Applicant s Background and Goals for Fellowship Training
Does the applicant have a solid academic record that supports their potential to successfully complete a combined degree training program?
Based on their academic accomplishments, does the applicant have the potential to develop into an independent and productive researcher?
Based on their course of study, does the applicant have the potential to successfully complete a combined degree training program?
Research Experience and Accomplishments
Does the applicant have sufficient familiarity and experience in conducting biomedical research?
How extensive is the applicant's prior biomedical research experience?
Are the gaps in the applicant's prior research experience well described and are the plans to address these gaps adequate?
When provided the opportunity, has the applicant contributed to any scientific papers or abstracts?
Has the applicant given an oral presentation at a national or international scientific conference?
If applicable, does the applicant's record of publication and conference presentation suggest future success as a productive biomedical researcher?
Personal Statement
Does the applicant's personal statement reveal realistic and strong motivation for pursuing a combined degree and a commitment to a future career as a clinician scientist?
Are the applicant's scientific and academic strengths appropriate and areas of growth achievable in order to advance their career in biomedical research based on their self-assessment?
Does the applicant understand the unique nature of a combined degree program and the synergistic benefits of integrating research and clinical training?
Does the applicant provide a sound rationale for why they are interested in becoming a clinician scientist?
Has the applicant provided a sound rationale for why they are interested in a combined degree program that involves conducting their dissertation research in an NIH IRP laboratory?
Reference Letters
Did the letters cite any strengths or weaknesses of the applicant that have the potential to impact their development into an independent and productive researcher?
If applicable, are the areas of growth necessary to advance the applicant's career in biomedical research achievable and appropriate?
Do the letters support the applicant's potential in completing a combined degree program?
Do the letters support the applicant's commitment to a career in biomedical research?
As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.
Protections for Human Subjects
For research that involves human subjects but does
not involve one of the categories of research that are exempt under 45 CFR Part
46, the committee will evaluate the justification for involvement of human
subjects and the proposed protections from research risk relating to their
participation according to the following five review criteria: 1) risk to
subjects, 2) adequacy of protection against risks, 3) potential benefits to the
subjects and others, 4) importance of the knowledge to be gained, and 5) data
and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or
more of the categories of research that are exempt under 45 CFR Part 46, the
committee will evaluate: 1) the justification for the exemption, 2) human
subjects involvement and characteristics, and 3) sources of materials. For
additional information on review of the Human Subjects section, please refer to
the Guidelines
for the Review of Human Subjects.
Inclusion of Women, Minorities, and Individuals Across the Lifespan
When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of individuals of all ages (including children and older adults) to determine if it is justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research.
The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following criteria: (1) description of proposed procedures involving animals, including species, strains, ages, sex, and total number to be used; (2) justifications for the use of animals versus alternative models and for the appropriateness of the species proposed; (3) interventions to minimize discomfort, distress, pain and injury; and (4) justification for euthanasia method if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals. Reviewers will assess the use of chimpanzees as they would any other application proposing the use of vertebrate animals. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.
Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
Not Applicable
Not Applicable
Not Applicable
As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.
Applications from Foreign Organizations
Not Applicable
Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Note: Effective for due dates on or after January 25, 2023, the Data Sharing Plan and Genomic Data Sharing Plan (GDS) will not be evaluated at time of review, and a Data Management and Sharing Plan is not applicable for this FOA.
Reviewers will comment on whether the Resource Sharing Plan(s) (i.e., Sharing Model Organisms) or the rationale for not sharing the resources, is reasonable.
Authentication of Key Biological and/or Chemical Resources
For projects involving key biological and/or chemical resources, reviewers will comment on the brief plans proposed for identifying and ensuring the validity of those resources.
Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s), convened by the Center for Scientific Review in accordance with NIH peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.
As part of the scientific peer review, all applications:
Applications will be assigned on the basis of established PHS referral guidelines to the appropriate NIH Institute or Center. Applications will compete for available funds with all other recommended applications . Following initial peer review, recommended applications will receive a second level of review by the appropriate NIH Institute or Center. The following will be considered in making funding decisions:
After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons. Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.
Information regarding the disposition of applications is available in the NIH Grants Policy Statement.
If the application is under consideration for funding, NIH
will request "just-in-time" information from the applicant as
described in the NIH
Grants Policy Statement.
A formal notification in the form of a Notice of Award (NoA) will be provided
to the applicant organization for successful applications. The NoA signed by
the grants management officer is the authorizing document and will be sent via
email to the recipient’s business official.
Recipients must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection
of an application for award is not an authorization to begin performance. Any
costs incurred before receipt of the NoA are at the recipient's risk. These
costs may be reimbursed only to the extent considered allowable pre-award costs.
Any application awarded in response to this FOA will be subject to terms and
conditions found on the Award
Conditions and Information for NIH Grants website. This includes any
recent legislation and policy applicable to awards that is highlighted on this
website.
Institutional Review Board or Independent Ethics Committee Approval: Recipient institutions must ensure that protocols are reviewed by their IRB or IEC. To help ensure the safety of participants enrolled in NIH-funded studies, the recipient must provide NIH copies of documents related to all major changes in the status of ongoing protocols.
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Recipients, and Activities, including of note, but not limited to:
If a recipient is successful and receives a Notice of Award, in accepting the award, the recipient agrees that any activities under the award are subject to all provisions currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.
Should the applicant organization sucessfully compete for an award, recipients of federal financial assistance (FFA) from HHS must administer their programs in compliance with federal civil rights laws that prohibit discrimination on the basis of race, color, national origin, disability, age and, in some circumstances, religion, conscience, and sex (including gender identity, sexual orientation, and pregnancy). This includes ensuring programs are accessible to persons with limited English proficiency and persons with disabilities. The HHS Office for Civil Rights provides guidance on complying with civil rights laws enforced by HHS. Please see https://www.hhs.gov/civil-rights/for-providers/provider-obligations/index.html and https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html
HHS recognizes that research projects are often limited in scope for many reasons that are nondiscriminatory, such as the principal investigator’s scientific interest, funding limitations, recruitment requirements, and other considerations. Thus, criteria in research protocols that target or exclude certain populations are warranted where nondiscriminatory justifications establish that such criteria are appropriate with respect to the health or safety of the subjects, the scientific study design, or the purpose of the research. For additional guidance regarding how the provisions apply to NIH grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this FOA.
Recipients of FFA must ensure that their programs are accessible to persons with limited English proficiency. For guidance on meeting the legal obligation to take reasonable steps to ensure meaningful access to programs or activities by limited English proficient individuals see https://www.hhs.gov/civil-rights/for-individuals/special-topics/limited-english-proficiency/fact-sheet-guidance/index.html and https://www.lep.gov.
Please contact the HHS Office for Civil Rights for more information about obligations and prohibitions under federal civil rights laws at https://www.hhs.gov/ocr/about-us/contact-us/index.html or call 1-800-368-1019 or TDD 1-800-537-7697.
Activation of the MSPP Award
The activation of the MSPP award is not automatic. If the
applicant receives a meritorious overall impact
score after the review of the MSPP application, s/he/they will be notified in
writing by receiving an Approval Letter that will include the terms and
conditions to activate the FM1 award. The applicant will then have a period of
up to 6 months to be accepted into both a clinical degree school and the NIH
IRP.
The following information for the Just In Time materials must include:
Transition after completion of Ph.D. dissertation research at the NIH IRP
While the MSPP Scholar is working at the NIH IRP conducting their Ph.D. dissertation research project, they will be supported by the NIH Intramural Research and Training Award. As such, the MSPP award will be paused and will need to be reactivated once the dissertation research has been completed in order to support the last 2 years of clinical degree training.
To avoid potential problems in reactivating the MSPP, applicants are strongly encouraged to submit their reactivation package no later than 2 months prior to the proposed return date to their clinical degree school.
The clinical degree school will submit an application on behalf of the applicant that must include:
These materials should be sent directly to the appropriate extramural office of the awarding NIH Institute or Center (IC). The original application plus one copy (preferably in PDF format) are to be e-mailed to the Financial or Grants Management contact person of the awarding NIH Institute or Center listed in the Notice of Award. The reactivation package will be evaluated by extramural program staff of the awarding component for completeness and appropriateness to the program.
Although the financial plans of the NIH Institute or Center provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds.
The taxability of stipends is described in the NIH Grants Policy Statement.
Fellowships funded primarily for educational purposes are exempted from the PHS invention requirements and thus invention reporting is not required. More details, including exceptions for fellows training at NIH are provided in the NIH Grants Policy Statement.
Note: The NIH Policy for Data Management and Sharing is effective for due dates on or after January 25, 2023.
Consistent with the NIH Policy for Data Management and Sharing, when data management and sharing is applicable to the award, recipients will be required to adhere to the Data Management and Sharing requirements as outlined in the NIH Grants Policy Statement.
Not applicable for fellowship awards .
When multiple years are involved, recipients will be required to submit the Research Performance Progress Report (RPPR) annually. The report is due two months before the beginning date of the next budget period and must include information describing the current year's progress as well as the research and training plans for the coming year. NIH FOAs outline intended research goals and objectives. Post award, NIH will review and measure performance based on the details and outcomes that are shared within the RPPR, as described at 45 CFR Part 75.301 and 2 CFR 200.301.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for recipients of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All recipients of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over the threshold. See the NIH Grants Policy Statement for additional information on this reporting requirement.
In carrying out its stewardship of human resource-related programs, the NIH may request information essential to an assessment of the effectiveness of this program from databases and from participants themselves. Participants may be contacted after the completion of this award for periodic updates on various aspects of their employment history, publications, support from research grants or contracts, honors and awards, professional activities, and other information helpful in evaluating the impact of the program.
The overall evaluation of the program will be based on metrics that will include, but are not limited to, the following:
For programs involving graduate students:
We encourage inquiries concerning this funding opportunity
and welcome the opportunity to answer questions from potential applicants.
eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues)
Finding Help Online: https://www.era.nih.gov/need-help
(preferred method of contact)
Telephone: 301-402-7469 or 866-504-9552 (Toll Free)
General Grants Information (Questions
regarding application instructions, application processes, and NIH grant
resources)
Email: GrantsInfo@nih.gov (preferred
method of contact)
Telephone: 301-480-7075
Grants.gov Customer Support (Questions regarding
Grants.gov registration and Workspace)
Contact Center Telephone: 800-518-4726
Email: support@grants.gov
Marie Mancini, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5032
Email: mancinim2@mail.nih.gov
Anissa Brown, PhD
National Institute of Dental and Craniofacial Research (NIDCR)
Research Training and Career Development Branch
Telephone: 301-594-4805
Email: anissa.brown@nih.gov
NIAID Training Help Desk
National Institute of Allergy and Infectious Diseases
(NIAID)
Telephone: 301-761-6203
Email: NIHMSPPQuestions@niaid.nih.gov
Center for Scientific Review (CSR)
Email: FOAReviewContact@csr.nih.gov
Erik Edgerton
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Tel: (301) 594-7760
Email: edgertont@mail.nih.gov
Samuel Ashe
National Institute of Allergy and Infectious Diseases
(NIAID)
Telephone: 301-435-4799
Email: samuel.ashe@nih.gov
Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Please note that the NIH Loan Repayment Programs (LRPs) are a set of programs to attract and retain promising early-stage investigators in research careers by helping them to repay their student loans. Recipients of fellowship awards are encouraged to consider applying for an extramural LRP award.
Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR 63A and 45 CFR Part 75 and 2 CFR Part 200.